Insulin Delivery Devices Global Market by Product, Data Validation, Analysis and Forecast 2022
ReportsWeb.com published “Insulin Delivery Devices Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, July 12, 2017 ) Increasing incidence of diabetes and favourable government policies are driving the market growth. Usage of other alternative mode of medication like oral drugs is hindering the market growth. Whereas huge research and development investment by market players seem to be opportunity factor to the market.
For more information http://www.reportsweb.com/insulin-delivery-devices-global-market-outlook-2016-2022
Insulin pens in product segment hold the largest market share in 2015, owing to high popularity and easy to use property. In end user segment Patients/Homecare segment accounted for the largest market share. It is due to increase in health care expenditure. North America accounted for the highest market share as compared to other regions. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of rising diabetic patients in this region.
Some of the key players in the market include Abbott Laboratories, Animas Corporation (Johnson and Johnson) , Becton, Dickinson and Company, Biocon Limited, ELI Lilly and Company, F. Hoffmann-La Roche, Ltd., Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi, Tandem Diabetes Care, Inc., Wockhardt Ltd. and Ypsomed Holding AG.
Applications Covered:
-Type II diabetes
-Type I diabetes
Products Covered:
-Pen Needles -Safety Pen Needles-Standard Pen Needles
-Insulin Syringes
-Insulin Pumps -Patch Pumps-External/Tethered Pumps
-Pens -Disposable Insulin Pens-Reusable Insulin Pens
-Other Insulin Delivery Devices
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001792562/sample
End Users Covered:
-Hospitals & Clinics
-Patients/Homecare
Regions Covered:
-North America-US-Canada-Mexico
-Europe-Germany-France-Italy-UK -Spain -Rest of Europe
-Asia Pacific-Japan -China -India -Australia -New Zealand -Rest of Asia Pacific
-Rest of the World-Middle East-Brazil-Argentina-South Africa-Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001792562/buying
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Insulin Delivery Devices Market, By Application
6 Global Insulin Delivery Devices Market, By Product
7 Global Insulin Delivery Devices Market, By End User
8 Global Insulin Delivery Devices Market, By Geography
9 Key Developments
10 Company Profiling
10.1 Abbott Laboratories
10.2 Animas Corporation (Johnson and Johnson)
10.3 Becton, Dickinson and Company
10.4 Biocon Limited
10.5 ELI Lilly and Company
10.6 F. Hoffmann-La Roche, Ltd.
10.7 Insulet Corporation
10.8 Medtronic PLC
10.9 Novo Nordisk A/S
10.10 Sanofi
10.11 Tandem Diabetes Care, Inc.
10.12 Wockhardt Ltd.
10.13 Ypsomed Holding AG
Purchase Report at http://www.reportsweb.com/buy&RW0001792562/buy/4150
For more information http://www.reportsweb.com/insulin-delivery-devices-global-market-outlook-2016-2022
Insulin pens in product segment hold the largest market share in 2015, owing to high popularity and easy to use property. In end user segment Patients/Homecare segment accounted for the largest market share. It is due to increase in health care expenditure. North America accounted for the highest market share as compared to other regions. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of rising diabetic patients in this region.
Some of the key players in the market include Abbott Laboratories, Animas Corporation (Johnson and Johnson) , Becton, Dickinson and Company, Biocon Limited, ELI Lilly and Company, F. Hoffmann-La Roche, Ltd., Insulet Corporation, Medtronic PLC, Novo Nordisk A/S, Sanofi, Tandem Diabetes Care, Inc., Wockhardt Ltd. and Ypsomed Holding AG.
Applications Covered:
-Type II diabetes
-Type I diabetes
Products Covered:
-Pen Needles -Safety Pen Needles-Standard Pen Needles
-Insulin Syringes
-Insulin Pumps -Patch Pumps-External/Tethered Pumps
-Pens -Disposable Insulin Pens-Reusable Insulin Pens
-Other Insulin Delivery Devices
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001792562/sample
End Users Covered:
-Hospitals & Clinics
-Patients/Homecare
Regions Covered:
-North America-US-Canada-Mexico
-Europe-Germany-France-Italy-UK -Spain -Rest of Europe
-Asia Pacific-Japan -China -India -Australia -New Zealand -Rest of Asia Pacific
-Rest of the World-Middle East-Brazil-Argentina-South Africa-Egypt
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001792562/buying
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Insulin Delivery Devices Market, By Application
6 Global Insulin Delivery Devices Market, By Product
7 Global Insulin Delivery Devices Market, By End User
8 Global Insulin Delivery Devices Market, By Geography
9 Key Developments
10 Company Profiling
10.1 Abbott Laboratories
10.2 Animas Corporation (Johnson and Johnson)
10.3 Becton, Dickinson and Company
10.4 Biocon Limited
10.5 ELI Lilly and Company
10.6 F. Hoffmann-La Roche, Ltd.
10.7 Insulet Corporation
10.8 Medtronic PLC
10.9 Novo Nordisk A/S
10.10 Sanofi
10.11 Tandem Diabetes Care, Inc.
10.12 Wockhardt Ltd.
10.13 Ypsomed Holding AG
Purchase Report at http://www.reportsweb.com/buy&RW0001792562/buy/4150
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results